Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Research suggests potential of anti-DNA MeTase antisense compounds

Jan. 22, 1997

URSO to be evaluated as chemopreventive for colorectal cancer

Jan. 21, 1997

Function of breast cancer gene described

Jan. 21, 1997

Zeneca's right to sell prostate cancer drug upheld

Jan. 20, 1997

EntreMed licenses dual cytotoxic/antiangiogenic compound

Jan. 20, 1997

Heterocyclic MDR inhibitors reported by Pfizer

Jan. 20, 1997

Daikin synthesizes new ganglioside compounds

Jan. 20, 1997

New tumor immunotherapy approach described by U.S. academic researchers

Jan. 17, 1997

Neovastat enters clinic in the U.S.

Jan. 17, 1997

SnET2 trials now span three continents

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...